Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Oly Katari
Institution:
National Institute of Pharmaceutical Education and Research
Observed institutions:
National Institute of Pharmaceutical Education and Research,
National Institute of Pharmaceutical Education and Research
ORCID:
0000-0002-5888-2531
Observed ORCID:
0000-0002-5888-2531
OpenAlex ID:
A5079377802
Nanoparticle-Based Drug Delivery System: The Magic Bullet for the Treatment of Chronic Pulmonary Diseases
2021
·
Sheersha Pramanik
, Sourav Mohanto
, et al.
·
Molecular Pharmaceutics
·
145
Recent advances in lipid-based long-acting injectable depot formulations
2023
·
Reena Sharma
, Sheetal Yadav
, et al.
·
Advanced Drug Delivery Reviews
·
69
Neoteric solvents for the pharmaceutical industry: an update
2021
·
Thenrajan Raja Sekharan
, Oly Katari
, et al.
·
Drug Discovery Today
·
43
Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics for the treatment of psoriasis
2021
·
Oly Katari
, Sanyog Jain
·
Expert Opinion on Drug Delivery
·
41
Unfolding the Potency of Adenosine in Targeting Triple Negative Breast Cancer via Paclitaxel-Incorporated pH-Responsive Stealth Liposomes
2022
·
Dasharath Chaudhari
, Oly Katari
, et al.
·
ACS Biomaterials Science & Engineering
·
35
Application of Design of Experiments® Approach-Driven Artificial Intelligence and Machine Learning for Systematic Optimization of Reverse Phase High Performance Liquid Chromatography Method to Analyze Simultaneously Two Drugs (Cyclosporin A and Etodolac) in Solution, Human Plasma, Nanocapsules, and Emulsions
2021
·
Syed Nazrin Ruhina Rahman
, Oly Katari
, et al.
·
AAPS PharmSciTech
·
35
Systematic Optimization, In Vitro Drug Release, and Preliminary Nonclinical Toxicity Assessment of Nonphospholipid-Based Topical Ophthalmic Emulsions Containing 0.05 or 0.1% w/w Cyclosporin A for Dry-Eye Syndrome Management
2019
·
Syed Nazrin Ruhina Rahman
, Datta Maroti Pawde
, et al.
·
AAPS PharmSciTech
·
25
Hyaluronic acid functionalized liposomes for co-delivery of paclitaxel and ursolic acid for enhanced efficacy against triple negative breast cancer
2024
·
Reena Sharma
, Vivek Yadav
, et al.
·
Journal of Drug Delivery Science and Technology
·
23
Enhancing oral bioavailability of dasatinib via supersaturable SNEDDS: Investigation of precipitation inhibition and IVIVC through in-vitro lipolysis-permeation model
2024
·
Dharshini Mageshvaran
, Sheetal Yadav
, et al.
·
International Journal of Pharmaceutics
·
23
Exploring the synergistic behavior of paclitaxel and vorinostat upon co-loading in albumin nanoparticles for breast cancer management
2023
·
Ashwin Abhang
, Oly Katari
, et al.
·
Drug Delivery and Translational Research
·
21
PDF
Gemini surfactants as next-generation drug carriers in cancer management
2024
·
Oly Katari
, Keshav Kumar
, et al.
·
Expert Opinion on Drug Delivery
·
19
Ionic liquid-based Ionogel: A novel strategy to improve dermal delivery and in vivo efficacy of etodolac in rheumatoid arthritis management
2024
·
Shrushti Bhamble
, Sayali Dighe
, et al.
·
Journal of Molecular Liquids
·
17
Dual acting oxaliplatin (IV) prodrug loaded albumin nanoparticles for safer synergistic anticancer action against triple negative breast cancer
2025
·
Kshitija Abhang
, Sayali Dighe
, et al.
·
Drug Delivery and Translational Research
·
13
Bifunctional Oxaliplatin (IV) Prodrug Based pH-Sensitive PEGylated Liposomes for Synergistic Anticancer Action Against Triple Negative Breast cancer
2024
·
Lavkesh Bhute
, Sayali Dighe
, et al.
·
AAPS PharmSciTech
·
12
Current Status on the Convergence of Artificial Intelligence and Formulation Development in Industry: A Review
2025
·
Siddhesh Warke
, Oly Katari
, et al.
·
AAPS PharmSciTech
·
9
Launching triple-hit chemo attack on TNBC through nanoparticle-mediated codelivery of cisplatin-chlorambucil conjugate and venetoclax
2024
·
Tushar Date
, Oly Katari
, et al.
·
International Journal of Pharmaceutics
·
8
Cisplatin(IV)-fatty acid prodrug-bound albumin nanoparticles: In vitro, in silico, and in vivo evaluation in breast cancer therapy
2026
·
Oly Katari
, Vivek Yadav
, et al.
·
Nanomedicine Nanotechnology Biology and Medicine
·
5
Topical delivery of cisplatin via ionic liquid-based gel: A localized strategy for triple-negative breast cancer treatment
2025
·
Oly Katari
, Smriti Bhardwaj
, et al.
·
Journal of Molecular Liquids
·
5
Micelles-based drug delivery for dementia
2022
·
Oly Katari
, Sheetal Yadav
, et al.
·
Elsevier eBooks
·
4
Overview of Tocol‐based Emulsions, Oxygen‐carrying Emulsions, Emulsions With Double or Triple Cargos and Emulsion‐like Dispersions
2020
·
Oly Katari
, Tamilvanan Shunmugaperumal
, et al.
·
Wiley eBooks
·
4
Albumin Nanoparticle-Based Delivery of Oxaliplatin-Oleic Acid Prodrug for Enhanced Breast Cancer Therapy
2026
·
Oly Katari
, S. Lokesh
, et al.
·
AAPS PharmSciTech
·
2
Crosslinked hydroxypropyl-β-cyclodextrin nanoparticles for improved efficacy of venetoclax against triple negative breast cancer
2025
·
Simran Chandani
, Sayali Dighe
, et al.
·
International Journal of Pharmaceutics
·
2
Nanomedicines to Improve Oral Delivery of Antiretroviral Drugs
2023
·
Oly Katari
, Sanyog Jain
·
AAPS advances in the pharmaceutical sciences series
·
1
Exploring Novel Strategies for Improving the Bioavailability of Docetaxel
2026
·
Oly Katari
, Siddhesh Warke
, et al.
·
AAPS PharmSciTech
Transdermal Ionic Liquid Gel of Erlotinib for Localized Breast Cancer Therapy
2026
·
Paulami Datta
, Oly Katari
, et al.
·
Pharmaceutical Research
Show more works
View as search
Works count:
30
Citation count:
561
H-index:
13
I10-index:
14
Year
Topic
Type